✦ LIBER ✦

Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia

✍ Scribed by Juana Serrano-López; Joaquin Sanchez-Garcia; Josefina Serrano; Miguel A. Alvarez-Rivas; Jose M. Garcia-Castellano; Jose Roman-Gomez; Olga de la Rosa; Concepcion Herrera-Arroyo; Antonio Torres-Gomez

Book ID: 109146331
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 700 KB
Volume: 51
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2010.03042.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Large-scale generation of autologous den

Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia

✍ Anita Schmitt; Peter Reinhardt; Iwona Hus; Jacek Tabarkiewicz; Jacek Roliñski; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Leukemic dendritic cells generated in th

Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia

✍ Woiciechowsky, A; Regn, S; Kolb, H-J; Roskrow, M 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB

Activated natural killer cells from pati

Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice

✍ Siegler, U; Kalberer, C P; Nowbakht, P; Sendelov, S; Meyer-Monard, S; Wodnar-Fil 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 277 KB

Pretransplant minimal residual disease l

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

✍ Venditti, A; Maurillo, L; Buccisano, F; Del Poeta, G; Mazzone, C; Tamburini, A; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Pretransplant minimal residual disease l

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

✍ Venditti, A; Maurillo, L; Buccisano, F; Del Poeta, G; Mazzone, C; Tamburini, A; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 27 KB

Use of peripheral blood stem cells for a

Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells

✍ Visani, G; Lemoli, R M; Tosi, P; Martinelli, G; Testoni, N; Ricci, P; Motta, M R 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB